当前位置:首页 - 行情中心 - 微电生理(688351) - 财务分析 - 现金流量表

微电生理

(688351)

  

流通市值:79.81亿  总市值:79.81亿
流通股本:4.71亿   总股本:4.71亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金281,478,570.67123,042,051.53515,644,197.36368,999,742.39
  收到的税费返还1,389,336.81-4,892,288.91807,469.88
  收到其他与经营活动有关的现金14,785,541.281,902,755.2112,986,584.639,038,352.14
  经营活动现金流入小计297,653,448.76124,944,806.74533,523,070.9378,845,564.41
  购买商品、接受劳务支付的现金158,738,074.5377,358,963.23197,997,702.27156,631,385.87
  支付给职工以及为职工支付的现金87,030,429.7544,760,188.98145,005,308.67109,097,275.19
  支付的各项税费8,212,480.54,634,562.4615,581,703.2915,602,650.84
  支付其他与经营活动有关的现金42,437,088.6620,288,852.5584,040,674.2360,695,760.22
  经营活动现金流出小计296,418,073.44147,042,567.22442,625,388.46342,027,072.12
  经营活动产生的现金流量净额1,235,375.32-22,097,760.4890,897,682.4436,818,492.29
二、投资活动产生的现金流量:
  收回投资收到的现金2,197,000,0001,025,000,0004,902,000,0003,943,000,000
  取得投资收益收到的现金7,802,136.824,278,643.1817,876,938.3314,044,007.52
  处置固定资产、无形资产和其他长期资产收回的现金净额55,286.255,286.22,450-
  处置子公司及其他营业单位收到的现金净额-5,000,000--
  投资活动现金流入小计2,204,857,423.021,034,333,929.384,919,879,388.333,957,044,007.52
  购建固定资产、无形资产和其他长期资产支付的现金27,462,883.498,048,745.91122,229,828.82107,498,804.11
  投资支付的现金2,007,440,251.98982,000,0004,875,511,378.793,715,158,600.04
  投资活动现金流出小计2,034,903,135.47990,048,745.914,997,741,207.613,822,657,404.15
  投资活动产生的现金流量净额169,954,287.5544,285,183.47-77,861,819.28134,386,603.37
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金---379,881.15
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---379,881.15
  分配股利、利润或偿付利息支付的现金9,882,602.71---
  支付其他与筹资活动有关的现金1,308,363.121,194,772.245,075,342.593,757,667.64
  筹资活动现金流出小计11,190,965.831,194,772.245,075,342.593,757,667.64
  筹资活动产生的现金流量净额-11,190,965.83-1,194,772.24-5,075,342.59-3,377,786.49
四、汇率变动对现金及现金等价物的影响-5,661,167.21-2,868,323.62-155,811.34690,731.79
五、现金及现金等价物净增加额154,337,529.8318,124,327.137,804,709.23168,518,040.96
  加:期初现金及现金等价物余额276,518,780.2276,518,780.21268,714,070.97268,714,070.97
  期末现金及现金等价物余额430,856,310.03294,643,107.34276,518,780.2437,232,111.93
补充资料:
  净利润40,085,267.73-51,082,300.24-
  资产减值准备2,693,036.7-1,213,967.77-
  固定资产和投资性房地产折旧10,967,693.97-17,834,872.21-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧10,967,693.97-17,834,872.21-
  无形资产摊销7,652,434.66-14,268,631.73-
  长期待摊费用摊销1,146,167.16-2,290,661.41-
  处置固定资产、无形资产和其他长期资产的损失-133,277.16--712,121.36-
  固定资产报废损失--13,748.41-
  公允价值变动损失-3,504,976.78--7,528,763.66-
  财务费用4,800,962.69-930,772.23-
  投资损失-23,605,020.26--7,860,780.25-
  递延所得税-139,836.6-147,892.52-
  其中:递延所得税资产减少-14,803.8-1,815,662.2-
    递延所得税负债增加-125,032.8--1,667,769.68-
  存货的减少-51,991,901.14--48,582,145.15-
  经营性应收项目的减少52,215,754.7-117,458.99-
  经营性应付项目的增加-49,102,840.94-55,794,196.68-
  其他6,914,829.52-4,243,891.54-
  现金的期末余额430,856,310.03-276,518,780.2-
  减:现金的期初余额276,518,780.2-268,714,070.97-
  现金及现金等价物的净增加额154,337,529.83-7,804,709.23-
公告日期2026-08-282026-04-302026-03-312025-10-28
审计意见(境内)标准无保留意见
TOP↑